These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 31986084)

  • 21. [Gut microbiota and graft-versus-host disease: broad-spectrum antibiotic use increases post-allogeneic hematopoietic stem cell transplant graft-versus-host disease-related mortality].
    Shono Y
    Rinsho Ketsueki; 2017; 58(7):835-842. PubMed ID: 28781282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbiome-intestine cross talk during acute graft-versus-host disease.
    Rafei H; Jenq RR
    Blood; 2020 Jul; 136(4):401-409. PubMed ID: 32526029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colonization with multidrug-resistant bacteria increases the risk of complications and a fatal outcome after allogeneic hematopoietic cell transplantation.
    Sadowska-Klasa A; Piekarska A; Prejzner W; Bieniaszewska M; Hellmann A
    Ann Hematol; 2018 Mar; 97(3):509-517. PubMed ID: 29255911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity.
    DeFilipp Z; Peled JU; Li S; Mahabamunuge J; Dagher Z; Slingerland AE; Del Rio C; Valles B; Kempner ME; Smith M; Brown J; Dey BR; El-Jawahri A; McAfee SL; Spitzer TR; Ballen KK; Sung AD; Dalton TE; Messina JA; Dettmer K; Liebisch G; Oefner P; Taur Y; Pamer EG; Holler E; Mansour MK; van den Brink MRM; Hohmann E; Jenq RR; Chen YB
    Blood Adv; 2018 Apr; 2(7):745-753. PubMed ID: 29592876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microbiota Manipulation With Prebiotics and Probiotics in Patients Undergoing Stem Cell Transplantation.
    Andermann TM; Rezvani A; Bhatt AS
    Curr Hematol Malig Rep; 2016 Feb; 11(1):19-28. PubMed ID: 26780719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Fructo-Oligosaccharide Prebiotic Is Well Tolerated in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I Dose-Escalation Trial.
    Andermann TM; Fouladi F; Tamburini FB; Sahaf B; Tkachenko E; Greene C; Buckley MT; Brooks EF; Hedlin H; Arai S; Mackall CL; Miklos D; Negrin RS; Fodor AA; Rezvani AR; Bhatt AS
    Transplant Cell Ther; 2021 Nov; 27(11):932.e1-932.e11. PubMed ID: 34274493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Gut Colonization by Antibiotic-Resistant Bacteria on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective, Single-Center Study.
    Bilinski J; Robak K; Peric Z; Marchel H; Karakulska-Prystupiuk E; Halaburda K; Rusicka P; Swoboda-Kopec E; Wroblewska M; Wiktor-Jedrzejczak W; Basak GW
    Biol Blood Marrow Transplant; 2016 Jun; 22(6):1087-1093. PubMed ID: 26900084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of microbiota in allogeneic hematopoietic stem cell transplantation.
    Chang CC; Hayase E; Jenq RR
    Expert Opin Biol Ther; 2021 Aug; 21(8):1121-1131. PubMed ID: 33412949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis.
    Haak BW; Prescott HC; Wiersinga WJ
    Front Immunol; 2018; 9():2042. PubMed ID: 30250472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut microbiota and allogeneic transplantation.
    Wang W; Xu S; Ren Z; Jiang J; Zheng S
    J Transl Med; 2015 Aug; 13():275. PubMed ID: 26298517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is it time to reconsider prophylactic antimicrobial use for hematopoietic stem cell transplantation? a narrative review of antimicrobials in stem cell transplantation.
    Jahan D; Peile E; Sheikh MA; Islam S; Parasnath S; Sharma P; Iskandar K; Dhingra S; Charan J; Hardcastle TC; Samad N; Chowdhury TS; Dutta S; Haque M
    Expert Rev Anti Infect Ther; 2021 Oct; 19(10):1259-1280. PubMed ID: 33711240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between oral and fecal microbiome dysbiosis and treatment complications in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation.
    Faraci M; Bonaretti C; Dell'Orso G; Pierri F; Giardino S; Angiero F; Blasi S; Farronato G; Di Marco E; Trevisiol A; Olcese E; Rufino L; Squillario M; Biassoni R
    Sci Rep; 2024 Mar; 14(1):6708. PubMed ID: 38509104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation.
    Peled JU; Devlin SM; Staffas A; Lumish M; Khanin R; Littmann ER; Ling L; Kosuri S; Maloy M; Slingerland JB; Ahr KF; Porosnicu Rodriguez KA; Shono Y; Slingerland AE; Docampo MD; Sung AD; Weber D; Alousi AM; Gyurkocza B; Ponce DM; Barker JN; Perales MA; Giralt SA; Taur Y; Pamer EG; Jenq RR; van den Brink MRM
    J Clin Oncol; 2017 May; 35(15):1650-1659. PubMed ID: 28296584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
    Vemuri RC; Gundamaraju R; Shinde T; Eri R
    Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Microbiome and Antibiotics in Autoimmune Diseases.
    Vangoitsenhoven R; Cresci GAM
    Nutr Clin Pract; 2020 Jun; 35(3):406-416. PubMed ID: 32319703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Multicenter Study of Bacterial Blood Stream Infections in Pediatric Allogeneic Hematopoietic Cell Transplantation Recipients: The Role of Acute Gastrointestinal Graft-versus-Host Disease.
    Satwani P; Freedman JL; Chaudhury S; Jin Z; Levinson A; Foca MD; Krajewski J; Sahdev I; Talekar MK; Gardenswartz A; Silverman J; Hayes M; Dvorak CC
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):642-647. PubMed ID: 28104513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preservation of the fecal microbiome is associated with reduced severity of graft-versus-host disease.
    Burgos da Silva M; Ponce DM; Dai A; M Devlin S; Gomes ALC; Moore G; Slingerland J; Shouval R; Armijo GK; DeWolf S; Fei T; Clurman A; Fontana E; Amoretti LA; Wright RJ; Andrlova H; Miltiadous O; Perales MA; Taur Y; Peled JU; van den Brink MRM
    Blood; 2022 Dec; 140(22):2385-2397. PubMed ID: 35969834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nutritional interventions in patients with graft-versus-host disease.
    Seguy D; Hueso T
    Curr Opin Clin Nutr Metab Care; 2023 Sep; 26(5):455-462. PubMed ID: 37389472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The microbiome of the critically ill patient.
    Akrami K; Sweeney DA
    Curr Opin Crit Care; 2018 Feb; 24(1):49-54. PubMed ID: 29257783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Impact of Antibiotic-Mediated Modification of the Intestinal Microbiome on Outcomes of Allogeneic Hematopoietic Cell Transplantation: Systematic Review and Meta-Analysis.
    Gavriilaki M; Sakellari I; Anagnostopoulos A; Gavriilaki E
    Biol Blood Marrow Transplant; 2020 Sep; 26(9):1738-1746. PubMed ID: 32447043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.